Home > Result Summaries: Compounds > H5N1 Pandemic Influenza Vaccine > Result Summary for 110464

Result Summary for 110464

Result Summary

Protocol ID:	110464
Clinical Study ID:	110464
Official Title:	A trial to evaluate the safety and immunogenicity of an investigational vaccination regimen in adults aged ≥18 years
Phase:	phase 3
Study Indications or Diseases:	Influenza
Generic Name:	H5N1 Pandemic Influenza Vaccine
Trade/Product Name:	Pandemrix
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Langley J et al. AS03-adjuvanted A/Indonesia/5/05 H5N1 pre pandemic vaccine consistently induces strong, broad and persistent immunity in young adults and the elderly. Abstract presented at Infectious Diseases Society of America (IDSA). Philadelphia, Pennsylvania, 29 October-1 November 2009. Langley JM et al. (2011) Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study. J Infect Dis. 203(12):1729-1738.